Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : Nvsef    crawled date : 2022 - 05 - 05    save search

BioMarin Hires Pharmaceutical Industry Leaders in Marketing and Accounting to Fill Strategic Roles Supporting Company's Growth Plans
Published: 2022-05-05 (Crawled : 21:00) - investors.biomarin.com
GLAXF | $20.2 510 twitter stocktwits trandingview |
Health Technology
| | O: -1.11% H: 2.28% C: -0.39%
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -10.81% H: 0.0% C: 0.0%
NVS | $93.81 1.34% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.26% H: 0.0% C: 0.0%
GSK | $39.605 0.85% 790K twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 0.75% C: 0.2%
BMRN S | $88.95 -1.24% 500K twitter stocktwits trandingview |
Health Technology
| | O: -1.18% H: 1.07% C: -2.15%

growth
Global Asthma and COPD Drugs Market Report to 2030 - Opportunity Analysis and Industry Forecasts
Published: 2022-05-05 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 510 twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.46% C: 0.46%
SNYNF | News | $92.7 600K twitter stocktwits trandingview |
Health Technology
| | O: 1.98% H: 0.0% C: -2.72%
AZNCF | $138.24 800 twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 1.57% C: -0.42%
NVS | $93.81 1.34% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.39% H: 0.15% C: -1.07%
GSK | $39.605 0.85% 790K twitter stocktwits trandingview |
Health Technology
| | O: -0.98% H: 0.0% C: 0.0%
ABT | News | $106.76 1.42% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.73% H: 0.12% C: -1.61%
SNY | News | $46.545 2.55% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.66% H: 0.0% C: 0.0%
AZN | $68.3 -0.09% 2M twitter stocktwits trandingview |
Health Technology
| | O: -1.35% H: 0.4% C: -1.2%

report market drug
BeiGene Reports First Quarter 2022 Financial Results
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
NVS | $93.81 1.34% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.39% H: 0.15% C: -1.07%
BGNE | $129.995 -1.49% 110K twitter stocktwits trandingview |
Health Technology
| | O: 0.98% H: 7.7% C: -2.09%

results
Incyte Announces European Commission Approval of Jakavi® (ruxolitinib) as the First Post-Steroid Treatment for Acute and Chronic Graft-Versus-Host Disease
Published: 2022-05-05 (Crawled : 10:00) - biospace.com/
NVS | $93.81 1.34% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.39% H: 0.15% C: -1.07%
INCY | $52.45 -0.7% 530K twitter stocktwits trandingview |
Health Technology
| | O: 3.73% H: 0.09% C: -3.98%

jakavi treatment disease approval
Gainers vs Losers
73% 27%

Top 10 Gainers
AGBA | News | $1.27 217.5% 120M twitter stocktwits trandingview |
Finance

EGOX | $0.054 50.0% 290M twitter stocktwits trandingview |

RWOD | $10.52 31.56% 5.9M twitter stocktwits trandingview |
n/a

ZCMD | $1.905 31.38% 30M twitter stocktwits trandingview |
Commercial Services

NVFY | $2.71 28.44% 31M twitter stocktwits trandingview |
Consumer Durables

MRDB 4 | $0.536 27.65% 2M twitter stocktwits trandingview |
n/a

BSFC | $0.0822 27.64% 75M twitter stocktwits trandingview |
Manufacturing

INDO | $5.1 25.0% 15M twitter stocktwits trandingview |
Energy Minerals

CHRO | $1.53 24.9% 100K twitter stocktwits trandingview |
n/a

AULT | $0.2998 23.83% 53M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.